Similar articles

• Pegvisomant Pfizer/Sensus.

  Goffin V, Touraine P. Goffin V, et al. Curr Opin Investig Drugs. 2004 Apr;5(4):463-8. Curr Opin Investig Drugs. 2004. PMID: 15134290 Review.
• [Growth hormone receptor antagonist in the treatment of acromegaly].

  Hubina E, Tóth A, Kovács GL, Dénes J, Kovács L, Góth M. Hubina E, et al. Orv Hetil. 2011 May 1;152(18):709-14. doi: 10.1556/OH.2011.29101. Orv Hetil. 2011. PMID: 21498159 Hungarian.
• Insights from growth hormone receptor blockade.

  Muller AF, van der Lely AJ. Muller AF, et al. Curr Opin Investig Drugs. 2004 Oct;5(10):1072-9. Curr Opin Investig Drugs. 2004. PMID: 15535428 Review.
• Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline.

  Giustina A, Ambrosio MR, Beck Peccoz P, Bogazzi F, Cannavo' S, De Marinis L, De Menis E, Grottoli S, Pivonello R. Giustina A, et al. J Endocrinol Invest. 2014 Oct;37(10):1017-30. doi: 10.1007/s40618-014-0146-x. Epub 2014 Sep 23. J Endocrinol Invest. 2014. PMID: 25245336 Free PMC article. No abstract available.
• Pegvisomant in the treatment of acromegaly.

  Parkinson C, Scarlett JA, Trainer PJ. Parkinson C, et al. Adv Drug Deliv Rev. 2003 Sep 26;55(10):1303-14. doi: 10.1016/s0169-409x(03)00111-x. Adv Drug Deliv Rev. 2003. PMID: 14499709 Review.